Biotech company Alnylam Pharmaceuticals conceded defeat for now in a lawsuit against Pfizer and BioNTech over technology in ...

The European Court of Justice Wednesday ruled there was no plausible reason to block the New York Times from getting European ...

In SELECT, semaglutide was associated with a 41% reduction in major CV events within 6 months — ie, before weight loss or ...

A top European court says the European Commission was wrong to refuse the New York Times access to text messages sent between ...

China said on Wednesday it would further enhance capital market support for science and technology innovation enterprises and ...

Revisions to classification criteria ‘will ensure homogeneous trial populations’ with data-driven scoring, a standardized MRI ...

After 6 months, placebo was associated with a mean weight gain of 0.4 kg (o.88 lb), compared with 1.2-1.9 kg (2.6-4.2 lb) ...

Drugmakers' shares fell globally after President Trump said he would [sign an executive order]( ...

Income investors have liked Pfizer (NYSE: PFE) for years. However, the big drugmaker's exceptionally juicy dividend these ...

Investing.com -- Moody’s Ratings has assigned an A2 rating to Pfizer Netherlands International Finance B.V. (PNIF BV), a ...

European Commission President Ursula von der Leyen lost a court fight against attempts to force her to disclose secret text ...

Although the immediate market response was negative, most pharmaceutical stocks recovered after Wall Street analysts ...